close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,014.52

-1.97%↓

JNJ

202.07

-1.79%↓

ABBV

228.32

-0.87%↓

UNH

331.69

-2.2%↓

AZN

90.21

-0.75%↓

LLY

1,014.52

-1.97%↓

JNJ

202.07

-1.79%↓

ABBV

228.32

-0.87%↓

UNH

331.69

-2.2%↓

AZN

90.21

-0.75%↓

LLY

1,014.52

-1.97%↓

JNJ

202.07

-1.79%↓

ABBV

228.32

-0.87%↓

UNH

331.69

-2.2%↓

AZN

90.21

-0.75%↓

LLY

1,014.52

-1.97%↓

JNJ

202.07

-1.79%↓

ABBV

228.32

-0.87%↓

UNH

331.69

-2.2%↓

AZN

90.21

-0.75%↓

LLY

1,014.52

-1.97%↓

JNJ

202.07

-1.79%↓

ABBV

228.32

-0.87%↓

UNH

331.69

-2.2%↓

AZN

90.21

-0.75%↓

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorGezondheidszorg

32.5 4

Strong Buy

Prijsupdate 4 dec 2025, 20:11 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

30.76

Max

33.31

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

-35M

Verkoop

70M

71M

Winstmarge

-49.028

Werknemers

143

EBITDA

66M

-34M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+32.73% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

847M

3B

Vorige openingsprijs

28.5

Vorige sluitingsprijs

32.5

Nieuwssentiment

By Acuity

50%

50%

167 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 dec 2025, 23:21 UTC

Winsten
Acquisities, Fusies, Overnames

EQB to Buy Loblaw Unit PC Financial for About $573.5 Million -- Update

DJ

Lezen

3 dec 2025, 23:14 UTC

Acquisities, Fusies, Overnames

EQB to Buy PC Financial From Loblaw for About $573.5 Million

DJ

Lezen

3 dec 2025, 22:01 UTC

Belangrijke Marktbewegers

Costco Wholesale Reports Higher Monthly Sales

DJ

Lezen

3 dec 2025, 21:38 UTC

Winsten

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500 Million

DJ

Lezen

3 dec 2025, 23:59 UTC

Marktinformatie

Australian Coal Prices Seen Having Recovered Well -- Market Talk

DJ

Lezen

3 dec 2025, 23:49 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

3 dec 2025, 23:49 UTC

Marktinformatie

HSBC Chair Appointment Unlikely to Have Material Operational Impact -- Market Talk

DJ

Lezen

3 dec 2025, 23:49 UTC

Marktinformatie

Nikkei May Decline Amid Caution Over U.S. Labor Market -- Market Talk

DJ

Lezen

3 dec 2025, 23:13 UTC

Marktinformatie

Australian Treasurer Says Economy Not On Drip of Govt Spending -- Market Talk

DJ

Lezen

3 dec 2025, 23:10 UTC

Winsten

Salesforce Raises Forecast as Agentforce Sales Top $500M -- Update

DJ

Lezen

3 dec 2025, 23:08 UTC

Marktinformatie

Goodman's New Bull Sees Profit Upgrade on Cards -- Market Talk

DJ

Lezen

3 dec 2025, 23:06 UTC

Acquisities, Fusies, Overnames

EQB to Buy Loblaw Unit PC Financial for About $573.5M -- Update

DJ

Lezen

3 dec 2025, 22:59 UTC

Acquisities, Fusies, Overnames

EQB to Buy PC Financial From Loblaw for About $573.5M

DJ

Lezen

3 dec 2025, 22:45 UTC

Marktinformatie

WiseTech Investor Day Increases Bull's Confidence -- Market Talk

DJ

Lezen

3 dec 2025, 22:20 UTC

Winsten

Salesforce CEO: 9,500 of 18,500 Total Closed Agentforce Deals Are Paid

DJ

Lezen

3 dec 2025, 22:19 UTC

Winsten

Salesforce CEO: Six Out of 10 Biggest Deals in 3Q Came from Agentforce

DJ

Lezen

3 dec 2025, 22:17 UTC

Winsten

Salesforce Working to Add Voice to Agentforce, CEO Says

DJ

Lezen

3 dec 2025, 22:16 UTC

Winsten

Salesforce CEO: Williams-Sonoma's Agentforce Makes Up 60% of Customer Chats

DJ

Lezen

3 dec 2025, 22:15 UTC

Winsten

Salesforce CEO: Agentforce ARR Was $540M in 3Q

DJ

Lezen

3 dec 2025, 22:10 UTC

Acquisities, Fusies, Overnames

EQB: Will Enter Into a Long-Term Strategic Relationship With Loblaw >EQB.T

DJ

Lezen

3 dec 2025, 22:09 UTC

Acquisities, Fusies, Overnames

EQB: Agreed to Acquire PC Fincl From Loblaw >EQB.T

DJ

Lezen

3 dec 2025, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

DJ

Lezen

3 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

3 dec 2025, 21:49 UTC

Winsten

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

DJ

Lezen

3 dec 2025, 21:23 UTC

Winsten

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500M

DJ

Lezen

3 dec 2025, 21:19 UTC

Winsten

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

DJ

Lezen

3 dec 2025, 21:06 UTC

Winsten

Salesforce Reports Mixed Earnings. The Stock Is Rising. -- Barrons.com

DJ

Lezen

3 dec 2025, 21:04 UTC

Winsten

Salesforce Sees Profitable Growth Framework Target of 50 by FY30 >CRM

DJ

Lezen

3 dec 2025, 21:04 UTC

Winsten

Salesforce Targets $60 B Plus Organic Rev by FY30 >CRM

DJ

Lezen

3 dec 2025, 21:03 UTC

Winsten

Salesforce Raises FY26 Oper Cash Flow Growth Guidance to 13% to 14% Y/Y >CRM

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

32.73% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 40.39 USD  32.73%

Hoogste 61 USD

Laagste 14.105 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

15 ratings

15

Buy

0

Hold

0

Sell

Gebaseerd op 15 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

167 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,014.52

↓-1.97%

JNJ

Johnson and Johnson

202.07

↓-1.79%

ABBV

AbbVie Inc

228.32

↓-0.87%

UNH

UnitedHealth Group Inc

331.69

↓-2.2%

AZN

AstraZeneca PLC ADR

90.21

↓-0.75%
help-icon Live chat